Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations.
Jui Wan LohAbner Herbert LimJason Yongsheng ChanYoon-Sim YapPublished in: Therapeutic advances in medical oncology (2023)
CNA status reveals differences in the genomic landscape. The implications of concurrent aberrations in other genes on chromosome 17 merit further research in ERBB2 non-neutral BCs.